The University of Florida is a public land-grant research university in Gainesville, Florida. It is a senior member of the State University System of Florida, traces its origins to 1853, and has operated continuously on its Gainesville campus since September 1906.

During the past decade, University of Florida conducted 642 clinical trials. In the 10-year time frame, 642 clinical trials started and 296 clinical trials were completed, i.e. on average, 46.1% percent of trials that started reached the finish line to date. In the past 5 years, 269 clinical trials started and 154 clinical trials were completed. i.e. 57.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida" #1 sponsor was "University of Florida" with 377 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials sponsored, "Gilead Sciences" with 21 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 20 trials sponsored and "Bristol-Myers Squibb" with 20 trials sponsored. Other sponsors include 689 different institutions and companies that sponsored additional 404 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida" #1 collaborator was "University of Florida" with 55 trials as a collaborator, "National Cancer Institute (NCI)" with 37 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 36 trials as a collaborator, "National Institute on Aging (NIA)" with 29 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 27 trials as a collaborator. Other collaborators include 1051 different institutions and companies that were collaborators in the rest 565 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida" are "Parkinson Disease" (26 trials), "Healthy" (21 trials), "Cystic Fibrosis" (17 trials), "Pulmonary Arterial Hypertension" (16 trials) and "Type 1 Diabetes Mellitus" (15 trials). Many other conditions were trialed in "University of Florida" in a lesser frequency.

Most popular intervention types in "University of Florida" are "Drug" (565 trials), "Other" (202 trials), "Device" (182 trials), "Behavioral" (108 trials) and "Procedure" (98 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (160 trials), "placebo" (19 trials), "Dexamethasone" (9 trials), "Cisplatin" (8 trials) and "Cytarabine" (6 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida" are 1080 trials for "All" genders, 42 trials for "Male" genders and 30 trials for "Female" genders.

Currently, there are 324 active trials in "University of Florida". 9 are not yet recruiting, 178 are recruiting, 121 are Active, not recruiting, and 16 are Enrolling by invitation. In total, there were 650 completed trials in University of Florida, undefined suspended trials, and 108 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida, 109 "Phase 1" clinical trials were conducted, 301 "Phase 2" clinical trials and 233 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 50 trials, and there were also 304 trials that are defined as “Not Applicable".

University of Florida has several departments that took part in Clinical trials: "UF Health Cancer Center" - 51 trials, "UF & Shands Orthopaedics and Sports Medicine Institute" - 28 trials, "Food Science and human nutrition department at University of Florida" - 23 trials, "UF Hepatology Research at CTRB" - 23 trials, "University of Florida College of Dentistry" - 20 trials, "University of Florida Hepatology" - 10 trials, "University of Florida College of Med., Department of Ophthalmology" - 10 trials, "Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy" - 8 trials, "University of Florida Institute on Aging" - 7 trials, "University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine" - 7 trials, "University of Florida, Department of Neurology" - 6 trials, "University of Florida-Department of Medicine" - 6 trials, "University of Florida Department of Psychiatry" - 5 trials, "Dental Clinical Research Unit, University of Florida" - 4 trials, "University of Florida - Division of Cardiology" - 4 trials, "University of Florida Division of Pulmonary, Critical Care, and Sleep Medicine" - 4 trials, "University of Florida - Division of Hematology & Oncology" - 4 trials, "EDGE Laboratory" - 3 trials, "University of Florida Hemophilia Treatment Center" - 3 trials, "University of Florida College of Medicine, Jacksonville - Rheumatology Research" - 3 trials, "Shands Medical Plaza and Cancer Center" - 3 trials, "University of Florida Dept of Genetics-Site Number:840083" - 2 trials, "Integrative Cardiovasculal Physiology Laboratory, University of Florida" - 2 trials, "Department of Neurology, McKnight Brain Institute" - 2 trials, "University of Florida, Department of Orthodontics" - 2 trials